Published: 2022-11-28

Perception on COVID-19 vaccines among the employees of Annamalai University, Chidambaram, Tamil Nadu: a cross sectional study

Abinayaa V., P. Kalyani, John William Felix A.


Background: The corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) was declared global pandemic in March 2020. Globally, this disease has caused more than 5.1 million deaths. Vaccines against COVID-19 considered as the most efficient way to stop the spread of this disease. The perception about the COVID vaccine has a greater impact on the vaccination against this disease. The objective of this study is to assess the Level of perception on COVID-19 vaccines and to find out the factors associated with level of perception on COVID-19 vaccines.

Methods: A descriptive cross-sectional study was conducted among 651 employees of Annamalai University during the month of October 2021 to March 2022. A pretested semi structure questionnaire was used to collect the data. Collected data was entered in Microsoft excel and analysis was done using statistical package of social sciences (SPSS) version 17.0.

Results: Out of 651 participants, 69.4% were males, 84% were married, 34.4% i.e., 225 participants belong to 41-50 age category. With mean age 41.78±9.708. 26.8% had a favorable perception towards vaccine. The level of perception is significantly associated with educational status and vaccination status of the study participant.

Conclusions: 45% of the participants had neutral level of perception on the COVID-19 vaccines. The educational status of the participant and favourable perception on the COVID-19 vaccines have the influence on the COVID vaccination status.



COVID19, Vaccines, Annamalai University, Perception

Full Text:



Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-60.

Weekly epidemiological update on COVID-19 - 14 September 2022. Available at: https://www.who. int/publications/m/item/weekly-epidemiological-update-on-covid-19---14-september-2022. Accessed on 18 October 2022.

Vitiello A, Ferrara F, Troiano V, La Porta R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357-60.

Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. npj Vaccines. 2021;6(1):1-7.

Rackimuthu S, Hasan MM, Bardhan M, Essar MY. COVID‐19 vaccination strategies and policies in India: The need for further re‐evaluation is a pressing priority. Int J Health Plann Manage. 2022;37(3):1847-50.

Tamil Nadu’s 85.71% population gets first dose of COVID-19 vaccine. The Hindu. 2021. Available at: 38044735.ece. Accessed on 18 October 2022.

Xing K, Tu XY, Liu M, Liang ZW, Chen JN, Li JJ, et al. Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(3):221-8.

Prakash A, Jeyakumar Nathan R, Kini S, Victor V. Message framing and COVID-19 vaccine acceptance among millennials in South India. PLoS One. 2022;17(7):e0269487.

Victor PJ, Mathews KP, Paul H, Mammen JJ, Murugesan M. Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India. Mayo Clin Proc. 2021;96(9):2493-4.

Martin LR, Petrie KJ. Understanding the Dimensions of Anti-Vaccination Attitudes: the Vaccination Attitudes Examination (VAX) Scale. Ann Behav Med. 2017;51(5):652-60.